Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Goel

Showing results (71-80 of 440) with videos related to

Pageof 44
Sort By:
Molecular Nutrition & Food Research|April 4, 2008
Multi-targeted therapy by curcumin: how spicy is it?Ajay Goel, Sonia Jhurani, Bharat B Aggarwal
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal CancerYinghui Zhao, Souvick Roy, Chuanxin Wang, et al.
International Journal of Cancer|June 10, 2003
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell linesChristian N Arnold, Ajay Goel, C Richard Boland
Biochemical Pharmacology|September 29, 2007
Curcumin as "Curecumin": from kitchen to clinicAjay Goel, Ajaikumar B Kunnumakkara, Bharat B Aggarwal
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Curcumin and Andrographis Exhibit Anti-Tumor Effects in Colorectal Cancer via Activation of Ferroptosis and Dual Suppression of Glutathione Peroxidase-4 and Ferroptosis Suppressor Protein-1Katsuki Miyazaki, Caiming Xu, Mitsuo Shimada, et al.
Gastroenterology|October 18, 2019
Pathways of Colorectal CarcinogenesisLong H Nguyen, Ajay Goel, Daniel C Chung
Yonsei Medical Journal|July 2, 2009
Promoter methylation in the genesis of gastrointestinal cancerClement Richard Boland, Sung Kwan Shin, Ajay Goel
Seminars in Cancer Biology|December 19, 2017
Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectivesHege Marie Vedeld, Ajay Goel, Guro E Lind
EMBO Molecular Medicine|November 10, 2025
circ-EGFR is a predictor of response to Cetuximab and a potential target in colorectal cancerSilei Sui, Yuan Li, Joan Maurel, et al.
Carcinogenesis|February 24, 2021
LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinomaYasuyuki Okada, Naoki Takahashi, Tetsuji Takayama, et al.
Pageof 44

Showing results (71-80 of 440) with videos related to

Sort By:
Pageof 44
Molecular Nutrition & Food Research|April 4, 2008
Multi-targeted therapy by curcumin: how spicy is it?Ajay Goel, Sonia Jhurani, Bharat B Aggarwal
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal CancerYinghui Zhao, Souvick Roy, Chuanxin Wang, et al.
International Journal of Cancer|June 10, 2003
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell linesChristian N Arnold, Ajay Goel, C Richard Boland
Biochemical Pharmacology|September 29, 2007
Curcumin as "Curecumin": from kitchen to clinicAjay Goel, Ajaikumar B Kunnumakkara, Bharat B Aggarwal
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Curcumin and Andrographis Exhibit Anti-Tumor Effects in Colorectal Cancer via Activation of Ferroptosis and Dual Suppression of Glutathione Peroxidase-4 and Ferroptosis Suppressor Protein-1Katsuki Miyazaki, Caiming Xu, Mitsuo Shimada, et al.
Gastroenterology|October 18, 2019
Pathways of Colorectal CarcinogenesisLong H Nguyen, Ajay Goel, Daniel C Chung
Yonsei Medical Journal|July 2, 2009
Promoter methylation in the genesis of gastrointestinal cancerClement Richard Boland, Sung Kwan Shin, Ajay Goel
Seminars in Cancer Biology|December 19, 2017
Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectivesHege Marie Vedeld, Ajay Goel, Guro E Lind
EMBO Molecular Medicine|November 10, 2025
circ-EGFR is a predictor of response to Cetuximab and a potential target in colorectal cancerSilei Sui, Yuan Li, Joan Maurel, et al.
Carcinogenesis|February 24, 2021
LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinomaYasuyuki Okada, Naoki Takahashi, Tetsuji Takayama, et al.
Pageof 44